NAD+ Anti-Aging Injections
Current understanding
Intravenous and intramuscular NAD+ (and precursor) injections are marketed through longevity clinics, med-spas, and unlicensed practitioners as anti-aging and energy therapy. Mechanistic rationale draws on NAD+ decline with age [mechanism-plausible]; direct human outcome evidence for injected protocols is minimal, dominated by small open-label and anecdotal reports [anecdotal-biohack]. The delivery channel is the main safety story: a 2026 CBS News report described an unlicensed Bronx practitioner charged with murder after a client died following an NAD injection [anecdotal-biohack].
Evidence log
- 2026-10-07 — Bronx clinic founder arrested on homicide charge after woman dies in ‘anti-aging’ procedure: cross-connection with longevity-clinics: The Bronx homicide-arrest incident links the unregulated clinic market to NAD injection practice specifically — the fatal procedure in prior reporting on this case was an anti-aging NAD injection administered by an unlicensed practitioner. (novelty: 3)
- 2026-10-06 — Unlicensed Bronx practitioner charged with murder in anti-aging NAD injection death: cross-connection with longevity-clinics: The Bronx fatality links the longevity-clinic trend to the NAD injection trend specifically through unlicensed delivery, suggesting the clinic model’s safety risks concentrate where popular injectables meet unregulated providers. (novelty: 3)